222 related articles for article (PubMed ID: 30367629)
1. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
[TBL] [Abstract][Full Text] [Related]
2. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.
Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE
Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062
[TBL] [Abstract][Full Text] [Related]
3. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED
Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449
[TBL] [Abstract][Full Text] [Related]
4. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Cd151 reduces mammary tumorigenesis in the MMTV/PyMT mouse model.
Roselli S; Kahl RG; Copeland BT; Naylor MJ; Weidenhofer J; Muller WJ; Ashman LK
BMC Cancer; 2014 Jul; 14():509. PubMed ID: 25012362
[TBL] [Abstract][Full Text] [Related]
6. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
[TBL] [Abstract][Full Text] [Related]
7. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
Zhang H; Kuang SQ; Liao L; Zhou S; Xu J
Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
[TBL] [Abstract][Full Text] [Related]
9. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET
Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376
[TBL] [Abstract][Full Text] [Related]
10. Deletion of
Martínez-Nieto G; Heljasvaara R; Heikkinen A; Kaski HK; Devarajan R; Rinne O; Henriksson C; Thomson E; von Hertzen C; Miinalainen I; Ruotsalainen H; Pihlajaniemi T; Karppinen SM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576139
[TBL] [Abstract][Full Text] [Related]
11. The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages.
Boyle ST; Faulkner JW; McColl SR; Kochetkova M
Mol Cancer; 2015 Jun; 14():115. PubMed ID: 26047945
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-Activated Cell Sorting of Murine Mammary Cancer Stem-Like Cell Subpopulations with HIF Activity.
Brooks DL; Seagroves TN
Methods Mol Biol; 2018; 1742():247-263. PubMed ID: 29330806
[TBL] [Abstract][Full Text] [Related]
13. PTEN PDZ-binding domain suppresses mammary carcinogenesis in the MMTV-PyMT breast cancer model.
Yan M; Wang Y; Wong CW; Or PM; Wong KL; Li L; Many AM; Guan H; Khoo US; Chan AM
Cancer Lett; 2018 Aug; 430():67-78. PubMed ID: 29772266
[TBL] [Abstract][Full Text] [Related]
14. CD24 Is Not Required for Tumor Initiation and Growth in Murine Breast and Prostate Cancer Models.
Cremers N; Neeb A; Uhle T; Dimmler A; Rothley M; Allgayer H; Fodde R; Sleeman JP; Thiele W
PLoS One; 2016; 11(3):e0151468. PubMed ID: 26978528
[TBL] [Abstract][Full Text] [Related]
15. Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer.
Guillory B; Sakwe AM; Saria M; Thompson P; Adhiambo C; Koumangoye R; Ballard B; Binhazim A; Cone C; Jahanen-Dechent W; Ochieng J
Am J Pathol; 2010 Nov; 177(5):2635-44. PubMed ID: 20847285
[TBL] [Abstract][Full Text] [Related]
16. Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.
Verbeke S; Richard E; Monceau E; Schmidt X; Rousseau B; Velasco V; Bernard D; Bonnefoi H; MacGrogan G; Iggo RD
Breast Cancer Res; 2014 Dec; 16(6):504. PubMed ID: 25527189
[TBL] [Abstract][Full Text] [Related]
17.
George AL; Boulanger CA; Anderson LH; Cagnet S; Brisken C; Smith GH
J Cell Sci; 2017 Jun; 130(12):2018-2025. PubMed ID: 28455412
[TBL] [Abstract][Full Text] [Related]
18. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
[TBL] [Abstract][Full Text] [Related]
19. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
[TBL] [Abstract][Full Text] [Related]
20. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.
Asselin-Labat ML; Sutherland KD; Vaillant F; Gyorki DE; Wu D; Holroyd S; Breslin K; Ward T; Shi W; Bath ML; Deb S; Fox SB; Smyth GK; Lindeman GJ; Visvader JE
Mol Cell Biol; 2011 Nov; 31(22):4609-22. PubMed ID: 21930782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
